APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Drugs Glass Packaging

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Parenteral Drugs Glass Packaging Market Outlook and Growth Opportunities 2026

28 December 2025191 pages

Choose your research edition.

Industry ResearchParenteral Drugs Glass Packaging Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Drugs Glass Packaging Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Parenteral Drugs Glass Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Drugs Glass Packaging Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Drugs Glass Packaging Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Parenteral Drugs Glass Packaging market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Parenteral Drugs Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral Drugs Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral Drugs Glass Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Parenteral Drugs Glass Packaging market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Parenteral Drugs Glass Packaging market include Ypsomed Holding AG, Gerresheimer AG, SiO2 Medical Products, Schott AG, Ompi Stevanato Group, Becton Dickinson and Company, MeadWestvaco Corporation, Unilife Corporation Inc and West Pharmaceutical Services, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parenteral Drugs Glass Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral Drugs Glass Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral Drugs Glass Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral Drugs Glass Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Parenteral Drugs Glass Packaging Segment by Company

Ypsomed Holding AG

Gerresheimer AG

SiO2 Medical Products

Schott AG

Ompi Stevanato Group

Becton Dickinson and Company

MeadWestvaco Corporation

Unilife Corporation Inc

West Pharmaceutical Services

Terumo Corporation

Berry Plastics Corporation

Owens-Illinois

RPC Group

Graphic Packaging Group

Parenteral Drugs Glass Packaging Segment by Type

Polyvinyl Chloride (PVC)

Polyolefin

Parenteral Drugs Glass Packaging Segment by Application

Large Volume Parenteral (LVP)

Small Volume Parenteral (SVP)

Parenteral Drugs Glass Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Parenteral Drugs Glass Packaging status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Parenteral Drugs Glass Packaging market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Parenteral Drugs Glass Packaging significant trends, drivers, influence factors in global and regions.

6. To analyze Parenteral Drugs Glass Packaging competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Drugs Glass Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Drugs Glass Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Drugs Glass Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parenteral Drugs Glass Packaging market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Parenteral Drugs Glass Packaging industry.

Chapter 3: Detailed analysis of Parenteral Drugs Glass Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Parenteral Drugs Glass Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Parenteral Drugs Glass Packaging in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Parenteral Drugs Glass Packaging Industry Trends Table 2. Parenteral Drugs Glass Packaging Industry Drivers Table 3. Parenteral Drugs Glass Packaging Industry Opportunities and Challenges Table 4. Parenteral Drugs Glass Packaging Industry Restraints Table 5. Global Parenteral Drugs Glass Packaging Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Parenteral Drugs Glass Packaging Revenue Share by Company (2021-2026) Table 7. Global Parenteral Drugs Glass Packaging Sales Volume by Company (k units) & (2021-2026) Table 8. Global Parenteral Drugs Glass Packaging Sales Volume Share by Company (2021-2026) Table 9. Global Parenteral Drugs Glass Packaging Average Price (USD/unit) of Company (2021-2026) Table 10. Global Parenteral Drugs Glass Packaging Company Ranking, (2024-2026) & (USD Million) Table 11. Global Parenteral Drugs Glass Packaging Key Company Manufacturing Base & Headquarters Table 12. Global Parenteral Drugs Glass Packaging Company, Product Type & Application Table 13. Global Parenteral Drugs Glass Packaging Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Parenteral Drugs Glass Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polyvinyl Chloride (PVC) Table 18. Significant Companies of Polyolefin Table 19. Global Parenteral Drugs Glass Packaging Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Parenteral Drugs Glass Packaging Sales Volume by Type (2021-2026) & (k units) Table 21. Global Parenteral Drugs Glass Packaging Sales Volume by Type (2027-2032) & (k units) Table 22. Global Parenteral Drugs Glass Packaging Sales Volume Share by Type (2021-2026) Table 23. Global Parenteral Drugs Glass Packaging Sales Volume Share by Type (2027-2032) Table 24. Global Parenteral Drugs Glass Packaging Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Parenteral Drugs Glass Packaging Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Parenteral Drugs Glass Packaging Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Parenteral Drugs Glass Packaging Sales Value Share by Type (2021-2026) Table 28. Global Parenteral Drugs Glass Packaging Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Large Volume Parenteral (LVP) Table 30. Significant Companies of Small Volume Parenteral (SVP) Table 31. Global Parenteral Drugs Glass Packaging Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Parenteral Drugs Glass Packaging Sales Volume by Application (2021-2026) & (k units) Table 33. Global Parenteral Drugs Glass Packaging Sales Volume by Application (2027-2032) & (k units) Table 34. Global Parenteral Drugs Glass Packaging Sales Volume Share by Application (2021-2026) Table 35. Global Parenteral Drugs Glass Packaging Sales Volume Share by Application (2027-2032) Table 36. Global Parenteral Drugs Glass Packaging Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Parenteral Drugs Glass Packaging Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Parenteral Drugs Glass Packaging Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Parenteral Drugs Glass Packaging Sales Value Share by Application (2021-2026) Table 40. Global Parenteral Drugs Glass Packaging Sales Value Share by Application (2027-2032) Table 41. Global Parenteral Drugs Glass Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Parenteral Drugs Glass Packaging Sales by Region (2021-2026) & (k units) Table 43. Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2021-2026) Table 44. Global Parenteral Drugs Glass Packaging Sales by Region (2027-2032) & (k units) Table 45. Global Parenteral Drugs Glass Packaging Sales Market Share by Region (2027-2032) Table 46. Global Parenteral Drugs Glass Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Parenteral Drugs Glass Packaging Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Parenteral Drugs Glass Packaging Sales Value Share by Region (2021-2026) Table 49. Global Parenteral Drugs Glass Packaging Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Parenteral Drugs Glass Packaging Sales Value Share by Region (2027-2032) Table 51. Global Parenteral Drugs Glass Packaging Market Average Price (USD/unit) by Region (2021-2026) Table 52. Global Parenteral Drugs Glass Packaging Market Average Price (USD/unit) by Region (2027-2032) Table 53. Global Parenteral Drugs Glass Packaging Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Parenteral Drugs Glass Packaging Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Parenteral Drugs Glass Packaging Sales by Country (2021-2026) & (k units) Table 56. Global Parenteral Drugs Glass Packaging Sales Market Share by Country (2021-2026) Table 57. Global Parenteral Drugs Glass Packaging Sales by Country (2027-2032) & (k units) Table 58. Global Parenteral Drugs Glass Packaging Sales Market Share by Country (2027-2032) Table 59. Global Parenteral Drugs Glass Packaging Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Parenteral Drugs Glass Packaging Sales Value Market Share by Country (2021-2026) Table 61. Global Parenteral Drugs Glass Packaging Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Parenteral Drugs Glass Packaging Sales Value Market Share by Country (2027-2032) Table 63. Ypsomed Holding AG Company Information Table 64. Ypsomed Holding AG Business Overview Table 65. Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Portfolio Table 67. Ypsomed Holding AG Recent Development Table 68. Gerresheimer AG Company Information Table 69. Gerresheimer AG Business Overview Table 70. Gerresheimer AG Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Gerresheimer AG Parenteral Drugs Glass Packaging Product Portfolio Table 72. Gerresheimer AG Recent Development Table 73. SiO2 Medical Products Company Information Table 74. SiO2 Medical Products Business Overview Table 75. SiO2 Medical Products Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. SiO2 Medical Products Parenteral Drugs Glass Packaging Product Portfolio Table 77. SiO2 Medical Products Recent Development Table 78. Schott AG Company Information Table 79. Schott AG Business Overview Table 80. Schott AG Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Schott AG Parenteral Drugs Glass Packaging Product Portfolio Table 82. Schott AG Recent Development Table 83. Ompi Stevanato Group Company Information Table 84. Ompi Stevanato Group Business Overview Table 85. Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Portfolio Table 87. Ompi Stevanato Group Recent Development Table 88. Becton Dickinson and Company Company Information Table 89. Becton Dickinson and Company Business Overview Table 90. Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Portfolio Table 92. Becton Dickinson and Company Recent Development Table 93. MeadWestvaco Corporation Company Information Table 94. MeadWestvaco Corporation Business Overview Table 95. MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 97. MeadWestvaco Corporation Recent Development Table 98. Unilife Corporation Inc Company Information Table 99. Unilife Corporation Inc Business Overview Table 100. Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Portfolio Table 102. Unilife Corporation Inc Recent Development Table 103. West Pharmaceutical Services Company Information Table 104. West Pharmaceutical Services Business Overview Table 105. West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Portfolio Table 107. West Pharmaceutical Services Recent Development Table 108. Terumo Corporation Company Information Table 109. Terumo Corporation Business Overview Table 110. Terumo Corporation Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Terumo Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 112. Terumo Corporation Recent Development Table 113. Berry Plastics Corporation Company Information Table 114. Berry Plastics Corporation Business Overview Table 115. Berry Plastics Corporation Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Berry Plastics Corporation Parenteral Drugs Glass Packaging Product Portfolio Table 117. Berry Plastics Corporation Recent Development Table 118. Owens-Illinois Company Information Table 119. Owens-Illinois Business Overview Table 120. Owens-Illinois Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Owens-Illinois Parenteral Drugs Glass Packaging Product Portfolio Table 122. Owens-Illinois Recent Development Table 123. RPC Group Company Information Table 124. RPC Group Business Overview Table 125. RPC Group Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. RPC Group Parenteral Drugs Glass Packaging Product Portfolio Table 127. RPC Group Recent Development Table 128. Graphic Packaging Group Company Information Table 129. Graphic Packaging Group Business Overview Table 130. Graphic Packaging Group Parenteral Drugs Glass Packaging Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Graphic Packaging Group Parenteral Drugs Glass Packaging Product Portfolio Table 132. Graphic Packaging Group Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Parenteral Drugs Glass Packaging Distributors List Table 136. Parenteral Drugs Glass Packaging Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Parenteral Drugs Glass Packaging Product Image Figure 2. Global Parenteral Drugs Glass Packaging Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 4. Global Parenteral Drugs Glass Packaging Sales (2021-2032) & (k units) Figure 5. Global Parenteral Drugs Glass Packaging Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Parenteral Drugs Glass Packaging Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polyvinyl Chloride (PVC) Image Figure 10. Polyolefin Image Figure 11. Global Parenteral Drugs Glass Packaging Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Parenteral Drugs Glass Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Parenteral Drugs Glass Packaging Sales Volume Share by Type (2021-2032) Figure 14. Global Parenteral Drugs Glass Packaging Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Parenteral Drugs Glass Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Parenteral Drugs Glass Packaging Sales Value Share by Type (2021-2032) Figure 17. Large Volume Parenteral (LVP) Image Figure 18. Small Volume Parenteral (SVP) Image Figure 19. Global Parenteral Drugs Glass Packaging Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Parenteral Drugs Glass Packaging Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Parenteral Drugs Glass Packaging Sales Volume Share by Application (2021-2032) Figure 22. Global Parenteral Drugs Glass Packaging Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Parenteral Drugs Glass Packaging Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Parenteral Drugs Glass Packaging Sales Value Share by Application (2021-2032) Figure 25. Global Parenteral Drugs Glass Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Parenteral Drugs Glass Packaging Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Parenteral Drugs Glass Packaging Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Parenteral Drugs Glass Packaging Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 30. North America Parenteral Drugs Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Parenteral Drugs Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Parenteral Drugs Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 36. South America Parenteral Drugs Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Parenteral Drugs Glass Packaging Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Parenteral Drugs Glass Packaging Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Parenteral Drugs Glass Packaging Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Parenteral Drugs Glass Packaging Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Polyvinyl Chloride (PVC)
  • Polyolefin
Applications
  • Large Volume Parenteral (LVP)
  • Small Volume Parenteral (SVP)
Companies covered
  • Ypsomed Holding AG
  • Gerresheimer AG
  • SiO2 Medical Products
  • Schott AG
  • Ompi Stevanato Group
  • Becton Dickinson and Company
  • MeadWestvaco Corporation
  • Unilife Corporation Inc
  • West Pharmaceutical Services
  • Terumo Corporation
  • Berry Plastics Corporation
  • Owens-Illinois
  • RPC Group
  • Graphic Packaging Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  4. 1.2.2 Global Parenteral Drugs Glass Packaging Sales Volume (2021-2032)
  5. 1.2.3 Global Parenteral Drugs Glass Packaging Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Parenteral Drugs Glass Packaging Market Dynamics
  1. 2.1 Parenteral Drugs Glass Packaging Industry Trends
  2. 2.2 Parenteral Drugs Glass Packaging Industry Drivers
  3. 2.3 Parenteral Drugs Glass Packaging Industry Opportunities and Challenges
  4. 2.4 Parenteral Drugs Glass Packaging Industry Restraints
3 Parenteral Drugs Glass Packaging Market by Company
  1. 3.1 Global Parenteral Drugs Glass Packaging Company Revenue Ranking in 2025
  2. 3.2 Global Parenteral Drugs Glass Packaging Revenue by Company (2021-2026)
  3. 3.3 Global Parenteral Drugs Glass Packaging Sales Volume by Company (2021-2026)
  4. 3.4 Global Parenteral Drugs Glass Packaging Average Price by Company (2021-2026)
  5. 3.5 Global Parenteral Drugs Glass Packaging Company Ranking (2024-2026)
  6. 3.6 Global Parenteral Drugs Glass Packaging Company Manufacturing Base and Headquarters
  7. 3.7 Global Parenteral Drugs Glass Packaging Company Product Type and Application
  8. 3.8 Global Parenteral Drugs Glass Packaging Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Parenteral Drugs Glass Packaging Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Parenteral Drugs Glass Packaging Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Parenteral Drugs Glass Packaging Market by Type
  1. 4.1 Parenteral Drugs Glass Packaging Type Introduction
  2. 4.1.1 Polyvinyl Chloride (PVC)
  3. 4.1.2 Polyolefin
  4. 4.2 Global Parenteral Drugs Glass Packaging Sales Volume by Type
  5. 4.2.1 Global Parenteral Drugs Glass Packaging Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Parenteral Drugs Glass Packaging Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Parenteral Drugs Glass Packaging Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Parenteral Drugs Glass Packaging Sales Value by Type
  9. 4.3.1 Global Parenteral Drugs Glass Packaging Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Parenteral Drugs Glass Packaging Sales Value by Type (2021-2032)
  11. 4.3.3 Global Parenteral Drugs Glass Packaging Sales Value Share by Type (2021-2032)
5 Parenteral Drugs Glass Packaging Market by Application
  1. 5.1 Parenteral Drugs Glass Packaging Application Introduction
  2. 5.1.1 Large Volume Parenteral (LVP)
  3. 5.1.2 Small Volume Parenteral (SVP)
  4. 5.2 Global Parenteral Drugs Glass Packaging Sales Volume by Application
  5. 5.2.1 Global Parenteral Drugs Glass Packaging Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Parenteral Drugs Glass Packaging Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Parenteral Drugs Glass Packaging Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Parenteral Drugs Glass Packaging Sales Value by Application
  9. 5.3.1 Global Parenteral Drugs Glass Packaging Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Parenteral Drugs Glass Packaging Sales Value by Application (2021-2032)
  11. 5.3.3 Global Parenteral Drugs Glass Packaging Sales Value Share by Application (2021-2032)
6 Parenteral Drugs Glass Packaging Regional Sales and Value Analysis
  1. 6.1 Global Parenteral Drugs Glass Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral Drugs Glass Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Parenteral Drugs Glass Packaging Sales by Region: 2021-2026
  4. 6.2.2 Global Parenteral Drugs Glass Packaging Sales by Region (2027-2032)
  5. 6.3 Global Parenteral Drugs Glass Packaging Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Parenteral Drugs Glass Packaging Sales Value by Region (2021-2032)
  7. 6.4.1 Global Parenteral Drugs Glass Packaging Sales Value by Region: 2021-2026
  8. 6.4.2 Global Parenteral Drugs Glass Packaging Sales Value by Region (2027-2032)
  9. 6.5 Global Parenteral Drugs Glass Packaging Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  12. 6.6.2 North America Parenteral Drugs Glass Packaging Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  15. 6.7.2 Europe Parenteral Drugs Glass Packaging Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Parenteral Drugs Glass Packaging Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  21. 6.9.2 South America Parenteral Drugs Glass Packaging Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Parenteral Drugs Glass Packaging Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Parenteral Drugs Glass Packaging Sales Value Share by Country, 2025 VS 2032
7 Parenteral Drugs Glass Packaging Country-level Sales and Value Analysis
  1. 7.1 Global Parenteral Drugs Glass Packaging Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Parenteral Drugs Glass Packaging Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Parenteral Drugs Glass Packaging Sales by Country (2021-2032)
  4. 7.3.1 Global Parenteral Drugs Glass Packaging Sales by Country (2021-2026)
  5. 7.3.2 Global Parenteral Drugs Glass Packaging Sales by Country (2027-2032)
  6. 7.4 Global Parenteral Drugs Glass Packaging Sales Value by Country (2021-2032)
  7. 7.4.1 Global Parenteral Drugs Glass Packaging Sales Value by Country (2021-2026)
  8. 7.4.2 Global Parenteral Drugs Glass Packaging Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Parenteral Drugs Glass Packaging Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Parenteral Drugs Glass Packaging Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Parenteral Drugs Glass Packaging Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ypsomed Holding AG
  2. 8.1.1 Ypsomed Holding AG Company Information
  3. 8.1.2 Ypsomed Holding AG Business Overview
  4. 8.1.3 Ypsomed Holding AG Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Ypsomed Holding AG Parenteral Drugs Glass Packaging Product Portfolio
  6. 8.1.5 Ypsomed Holding AG Recent Developments
  7. 8.2 Gerresheimer AG
  8. 8.2.1 Gerresheimer AG Company Information
  9. 8.2.2 Gerresheimer AG Business Overview
  10. 8.2.3 Gerresheimer AG Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Gerresheimer AG Parenteral Drugs Glass Packaging Product Portfolio
  12. 8.2.5 Gerresheimer AG Recent Developments
  13. 8.3 SiO2 Medical Products
  14. 8.3.1 SiO2 Medical Products Company Information
  15. 8.3.2 SiO2 Medical Products Business Overview
  16. 8.3.3 SiO2 Medical Products Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SiO2 Medical Products Parenteral Drugs Glass Packaging Product Portfolio
  18. 8.3.5 SiO2 Medical Products Recent Developments
  19. 8.4 Schott AG
  20. 8.4.1 Schott AG Company Information
  21. 8.4.2 Schott AG Business Overview
  22. 8.4.3 Schott AG Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Schott AG Parenteral Drugs Glass Packaging Product Portfolio
  24. 8.4.5 Schott AG Recent Developments
  25. 8.5 Ompi Stevanato Group
  26. 8.5.1 Ompi Stevanato Group Company Information
  27. 8.5.2 Ompi Stevanato Group Business Overview
  28. 8.5.3 Ompi Stevanato Group Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Ompi Stevanato Group Parenteral Drugs Glass Packaging Product Portfolio
  30. 8.5.5 Ompi Stevanato Group Recent Developments
  31. 8.6 Becton Dickinson and Company
  32. 8.6.1 Becton Dickinson and Company Company Information
  33. 8.6.2 Becton Dickinson and Company Business Overview
  34. 8.6.3 Becton Dickinson and Company Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Becton Dickinson and Company Parenteral Drugs Glass Packaging Product Portfolio
  36. 8.6.5 Becton Dickinson and Company Recent Developments
  37. 8.7 MeadWestvaco Corporation
  38. 8.7.1 MeadWestvaco Corporation Company Information
  39. 8.7.2 MeadWestvaco Corporation Business Overview
  40. 8.7.3 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 MeadWestvaco Corporation Parenteral Drugs Glass Packaging Product Portfolio
  42. 8.7.5 MeadWestvaco Corporation Recent Developments
  43. 8.8 Unilife Corporation Inc
  44. 8.8.1 Unilife Corporation Inc Company Information
  45. 8.8.2 Unilife Corporation Inc Business Overview
  46. 8.8.3 Unilife Corporation Inc Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Unilife Corporation Inc Parenteral Drugs Glass Packaging Product Portfolio
  48. 8.8.5 Unilife Corporation Inc Recent Developments
  49. 8.9 West Pharmaceutical Services
  50. 8.9.1 West Pharmaceutical Services Company Information
  51. 8.9.2 West Pharmaceutical Services Business Overview
  52. 8.9.3 West Pharmaceutical Services Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 West Pharmaceutical Services Parenteral Drugs Glass Packaging Product Portfolio
  54. 8.9.5 West Pharmaceutical Services Recent Developments
  55. 8.10 Terumo Corporation
  56. 8.10.1 Terumo Corporation Company Information
  57. 8.10.2 Terumo Corporation Business Overview
  58. 8.10.3 Terumo Corporation Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Terumo Corporation Parenteral Drugs Glass Packaging Product Portfolio
  60. 8.10.5 Terumo Corporation Recent Developments
  61. 8.11 Berry Plastics Corporation
  62. 8.11.1 Berry Plastics Corporation Company Information
  63. 8.11.2 Berry Plastics Corporation Business Overview
  64. 8.11.3 Berry Plastics Corporation Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Berry Plastics Corporation Parenteral Drugs Glass Packaging Product Portfolio
  66. 8.11.5 Berry Plastics Corporation Recent Developments
  67. 8.12 Owens-Illinois
  68. 8.12.1 Owens-Illinois Company Information
  69. 8.12.2 Owens-Illinois Business Overview
  70. 8.12.3 Owens-Illinois Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Owens-Illinois Parenteral Drugs Glass Packaging Product Portfolio
  72. 8.12.5 Owens-Illinois Recent Developments
  73. 8.13 RPC Group
  74. 8.13.1 RPC Group Company Information
  75. 8.13.2 RPC Group Business Overview
  76. 8.13.3 RPC Group Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 RPC Group Parenteral Drugs Glass Packaging Product Portfolio
  78. 8.13.5 RPC Group Recent Developments
  79. 8.14 Graphic Packaging Group
  80. 8.14.1 Graphic Packaging Group Company Information
  81. 8.14.2 Graphic Packaging Group Business Overview
  82. 8.14.3 Graphic Packaging Group Parenteral Drugs Glass Packaging Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Graphic Packaging Group Parenteral Drugs Glass Packaging Product Portfolio
  84. 8.14.5 Graphic Packaging Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parenteral Drugs Glass Packaging Value Chain Analysis
  2. 9.1.1 Parenteral Drugs Glass Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parenteral Drugs Glass Packaging Sales Mode & Process
  6. 9.2 Parenteral Drugs Glass Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parenteral Drugs Glass Packaging Distributors
  9. 9.2.3 Parenteral Drugs Glass Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst